
The Executive Director, Biotech Portfolio Lead (BPL) is an enterprise commercial leader accountable for the strategic direction, commercial performance, and delivery excellence of Fortrea’s most critical biotech client portfolios. Serving as executive sponsor for a regional portfolio of strategic biotech partners, this role owns the long‑term health, growth, and outcomes of complex, multi‑program relationships.
The BPL provides executive‑level continuity across the full client lifecycle, maintaining clear line of sight across all portfolio work to enable proactive planning, predictable execution, and alignment with sponsor scientific strategy, clinical development priorities, and business objectives. Through strategic portfolio leadership, executive client engagement, and cross‑functional collaboration, the BPL drives sustained partnership growth, supports business development, and strengthens Fortrea’s reputation as a trusted leader in biotech strategy and delivery.
of Responsibilities:
Strategic Operational Leadership
Client Relationship Leadership
Partnership Portfolio Oversight and Accountability
Departmental and Organizational Leadership
Qualifications (Minimum Required):
Experience (Minimum Required):
Physical Demands / Work Environment:
Work Environment:
Physical Requirements:
Pay Range: $230,000-$250,000 (The range does not include benefits, and if applicable, bonus, commission, or equity)
Benefits: All job offers will be based on a candidate’s skills and prior relevant experience, applicable degrees/certifications, as well as internal equity and market data. Regular, full-time or part-time employees working 20 or more hours per week are eligible for comprehensive benefits including: Medical, Dental, Vision, Life, STD/LTD, 401(K), ESPP, Paid time off (PTO) or Flexible time off (FTO), and Company bonus where applicable. For more detailed information, please click here.
Application deadline: May22, 2026
Learn more about our EEO & Accommodations request here

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators.
Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas.
Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes.
Together, exceptional is possible.
Learn more at Fortrea.com